溶解性 | DMSO 97 mg/mL Water <1 mg/mL Ethanol 15 mg/mL |
存贮条件 | 储存温度-20°C |
应用 | An irreversible and potent EGFR/Neu inhibitor, inhibits EGFR phosphorylation |
产品介绍 | Afatinib (BIBW2992) is an irreversible EGFR/Neu inhibitor with an IC50 of 14 nM. Afatinib is a potent inhibitor of EGFR phosphorylation. Afatinib showed positive results in assays against a variety of human cancer cell lines, including A431, murine NIH-3T3 cells, and breast cancer cell line BT-474. |
备注 | Afatinib (BIBW2992) irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L858R), EGFR(L858R/T790M) and HER2 with IC50 of 0.5 nM, 0.4 nM, 10 nM and 14 nM, respectively; 100-fold more active against Gefitinib-resistant L858R-T790M E |
别名 | Tomtovok;阿法替尼;BIBW2992;N-[4-[(3-氯-4-氟苯基)氨基]-7-[[(3S)-四氢-3-呋喃基]氧基]-6-喹唑啉基]-4-(二甲基氨基)-2-丁烯酰胺;Tomtovok;(S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;BIBW2992 |
阿法替尼
Afatinib (订货以英文为准)
编号:A129323
CAS号:439081-18-2
分子式:C24H25CLFN5O3
分子量:485.94
产品名称 | Afatinib |
中文名称 | 阿法替尼 |
CAS号 | 439081-18-2 |
分子式(M.F.) | C24H25CLFN5O3 |
分子量(M.W.) | 485.94 |
储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品